VOYA INVESTMENT MANAGEMENT LLC - INVIVO THERAPEUTICS HLDGS CO ownership

INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 55 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2015. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q1 2017$59,000
-3.3%
14,5500.0%0.00%
Q4 2016$61,000
-38.4%
14,5500.0%0.00%
Q3 2016$99,000
+17.9%
14,5500.0%0.00%
Q2 2016$84,000
-17.6%
14,5500.0%0.00%
Q1 2016$102,000
-2.9%
14,5500.0%0.00%
Q4 2015$105,000
-16.0%
14,5500.0%0.00%
Q3 2015$125,000
-46.8%
14,5500.0%0.00%
-100.0%
Q2 2015$235,00014,5500.00%
Other shareholders
INVIVO THERAPEUTICS HLDGS CO shareholders Q4 2015
NameSharesValueWeighting ↓
IMS Capital Management 246,966$1,778,0002.19%
WELCH & FORBES LLC 902,286$6,496,0000.21%
Alambic Investment Management, L.P. 25,100$181,0000.11%
EMERSON INVESTMENT MANAGEMENT, LLC 74,175$534,0000.10%
Hayek Kallen Investment Management 10,965$79,0000.06%
Yellowstone Partners, LLC 10,045$72,0000.03%
Ausdal Financial Partners, Inc. 7,750$56,0000.03%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 29,647$213,0000.03%
GROUP ONE TRADING, L.P. 61,856$445,0000.01%
Cambridge Investment Research Advisors, Inc. 10,500$76,0000.00%
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders